Noticias y Actividades de Encoded Therapeutics
Ejecutivos
Ver el organigrama con sus 23 ejecutivos principales
Biografías más buscadas en Encoded Therapeutics
- Kartik Ramamoorthi, Chief Executive Officer and Director
- Karan Takhar, Director
- Sean Nolan, Chairman of the Board
Recientes movimientos de ejecutivos en Encoded Therapeutics
- Jack Kane, Vice President, Engineering, ha dejado la empresa (noticia publicada el 22 de junio de 2026).
- Joseph Sullivan, se ha incorporado a la empresa como Vice President of Clinical Development (noticia publicada el 18 de diciembre de 2025).
Crear su alerta
para seguir los movimientos de los ejecutivos en Encoded Therapeutics.
Biotecnología
Encoded Therapeutics tiene 2.430 competidores entre los que se incluyen Lonza (Suiza), Vertex Pharmaceuticals (Estados Unidos) y Eurofins (Luxemburgo).
Popular M&A news in Biotecnología
- Eli Lilly has announced the acquisition of AtaiBeckley (publicado el 17 de julio de 2026).
- GSK ha Nuvalent adquirido (publicado el 17 de julio de 2026).
- Clearside Biomedical has gone out of its bankruptcy protection (publicado el 15 de julio de 2026).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de Encoded Therapeutics
- Encoded Demonstrates Therapeutic Potential of a Vectorized miRNA-based Approach for Angelman Syndrome at the FAST Annual Global Science Summit
- Encoded Therapeutics Presents Preclinical Data Across its Gene Therapy Portfolio at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
- Encoded Therapeutics Provides Pipeline Updates From Its Vector Engineering Platform Ahead of Four Preclinical Presentations at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
- Encoded Therapeutics Announces UK CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101
- Encoded Therapeutics Announces US IND Clearance and Australian CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101
- Our platform to discover and validate regulatory elements to drive targeted transgene expression for use in gene therapies
- Encoded Therapeutics Addresses Common Source of Gene Therapy Toxicity While Achieving Precise Brain Expression in Non-Human Primates, Presented at the American Society of Gene and Cell Therapy 26th Annual Meeting
- Building Customized Gene Expression Profiles
- Gene therapy targets interneurons to tackle Dravet syndrome | Spectrum | Autism Research News
- Enabling Precise Control of Expression for Potentially Improved Gene Therapy Safety and Efficacy Profiles
- View more press releases Close
Redes sociales sobre Encoded Therapeutics
- Encoded Therapeutics en Wikipedia, Google News y Yahoo Finance
- Encoded Therapeutics en LinkedIn, Twitter y YouTube
